• Neurology

    NEUROLOGY

    Learn about Alzheimer's Disease

    Smoldering Alzheimer's Disease

    Learn More

Eisai Neurology is aiming to revolutionize drug discovery and develop targeted medicines for some of the world's most challenging neurological conditions, such as Alzheimer's disease (AD).

Smoldering AD: Pathology Beyond Amyloid Plaque

Learn how different amyloid species contribute to the ongoing neurotoxic process in AD

Blood-Based Biomarkers in AD

Learn about blood based biomarkers in AD and its impact on clinical diagnosis

Time is Brain: Early AD Patient Identification and Diagnosis

Learn why early identification and diagnosis of AD can be crucial for your patients

Understanding ARIA

Learn how to identify Amyloid-Related Imaging Abnormalities (ARIA) using MRI

Locate your Medical Science Liaison (MSL)

Request contact information of your MSL

Eisai Medical Information

Submit medical inquiries and find information on Eisai Neurology FDA-approved products and investigational agents

Independent Medical Education

Explore active and upcoming independent, accredited continuing medical education (CME) activities supported by Eisai through educational grants

Congress Materials

Learn about the latest Eisai research in neurology

Diagnostic Test Information

Learn more about biomarker testing options for AD Diagnosis

Early AD Patient Care Pathway

Learn about early AD patient care pathway solutions for your practice

Clinical Trials

Notepad

Clinical Trials

Eisai has numerous drug candidates in clinical development and is actively recruiting for trials in neurology.

Explore Clinical Trials

Grants

Support

Grants

This website provides policies and procedures for the preparation and submission of requests for Medical Education Grants (ME) and Investigator-Initiated Studies (IIS).

Explore Eisai Grants Process